BridgeBio Pharma, Inc. - BBIO

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$16.83B
QoQ value delta ($000)
+$1.407B (+9.12%)
Implied price effect (QoQ)
-1.58%
Shares
Total shares
226,483,204
QoQ shares delta
+22,217,580 (+10.88%)
Total shares held by funds (by quarter)

Market chart (BBIO)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 460 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
VANGUARD GROUP INC 1,289,827 16,862,691 0.02%
BlackRock, Inc. 1,055,068 14,207,757 0.02%
Kohlberg Kravis Roberts & Co. L.P. 984,759 13,260,971 18.42%
JANUS HENDERSON GROUP PLC 978,607 13,179,013 0.47%
VIKING GLOBAL INVESTORS LP 879,419 11,842,434 2.46%
FARALLON CAPITAL MANAGEMENT LLC 695,479 9,365,463 3.96%
VANGUARD PORTFOLIO MANAGEMENT LLC 600,063 8,080,573 0.03%
VANGUARD CAPITAL MANAGEMENT LLC 576,220 7,759,495 0.01%
UBS Group AG 437,415 5,890,321 0.07%
Aisling Capital Management LP 377,954 5,089,611 79.35%
GEODE CAPITAL MANAGEMENT, LLC 371,928 4,918,030 0.02%
JANE STREET GROUP, LLC 366,493 4,935,272 0.05%
STATE STREET CORP 366,422 4,934,320 0.01%
Invesco Ltd. 341,062 4,592,814 0.05%
PRICE T ROWE ASSOCIATES INC /MD/ 282,312 3,801,655 0.03%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 267,873 3,607,243 0.03%
Frazier Life Sciences Management, L.P. 256,058 3,448,139 6.59%
CITADEL ADVISORS LLC 251,759 3,390,240 0.04%
TWO SIGMA INVESTMENTS, LP 231,738 3,120,631 0.19%
D. E. Shaw & Co., Inc. 189,027 2,545,486 0.11%
Polar Capital Holdings Plc 187,083 2,519,306 0.66%
WELLINGTON MANAGEMENT GROUP LLP 184,458 2,483,953 0.03%
FRANKLIN RESOURCES INC 181,114 2,438,925 0.04%
FMR LLC 174,047 2,343,754 0.01%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 146,817 1,977,080 0.13%